DOI: 10.2337/dc07-1525
RACIAL DISPARITY IN GLUCAGON-LIKE PEPTIDE 1 (GLP-1) AND INFLAMMATION MARKERS AMONG SEVERELY OBESE ADOLESCENTS
1Pediatrics, pvelasquez{at}utmem.edu ABSTRACT Objective: Compared with Caucasians (C), obese African-American (AA) adolescents have higher risk for type 2 diabetes. Subclinical inflammation and reduced GLP-1 concentration are linked to the pathogenesis of the disease. We determined the relationship between insulin resistance, β-cell activity, and sub-clinical inflammation with GLP-1 concentrations, and whether racial disparities in GLP-1 response were present in 49 obese adolescents (14 ± 3 y, 76% AA, 71% female).
Research Design And Methods: Subjects underwent physical examination and an oral glucose tolerance test. We measured levels of high sensitivity CRP (CRPhs), fibrinogen, glucose, GLP-1total, GLP-1active, and insulin. Insulin and glucose area under the curve, insulinogenic index (
Results: No racial differences were seen in mean or relative BMI. Thirty-five percent of subjects had altered fasting or 2-hour glucose levels (AA vs. C, P = NS), and 75% were INF+ (AA vs C, P = 0.046). Glucose and insulin, CISI, and Conclusion: AAs exhibited lower GLP-1 concentrations and increased inflammatory response. Both mechanisms may act synergistically to enhance obese AA predisposition to type 2 diabetes. Our findings might be relevant to effective deployment of emerging GLP-1-based treatments across ethnicities.
This article has been cited by other articles:
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||